| Fund ID | 805-1717867025 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 25% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Oberland Capital Healthcare Master Fund III LP | Private Equity | $1.18B |
| Oberland Capital Healthcare Solutions Master Fund LP | Private Equity | $624.8M |
| Oberland Capital Healthcare Master Fund II LP | Private Equity | $481M |
Quantbio Innovations Fund LP reports $6.3 million in gross assets, among the top 82% of private funds by size.
The stated minimum investment is $150,000.
Quantbio Innovations Fund LP is managed by Oberland Capital Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.